Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy

BACKGROUND: Immune checkpoint inhibitors (ICI) are regarded as a standard of care in multiple malignancies. We hypothesized that serum parameters are of prognostic value in ICI treated patients suffering from solid tumours. METHODS: Data from 114 patients treated with ICIs for solid malignancies fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Minichsdorfer, Christoph, Gleiss, Andreas, Aretin, Marie-Bernadette, Schmidinger, Manuela, Fuereder, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103267/
https://www.ncbi.nlm.nih.gov/pubmed/35535695
http://dx.doi.org/10.1080/07853890.2022.2070660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103267/
https://www.ncbi.nlm.nih.gov/pubmed/35535695
http://dx.doi.org/10.1080/07853890.2022.2070660

Ejemplares similares